JP2008526854A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526854A5 JP2008526854A5 JP2007550431A JP2007550431A JP2008526854A5 JP 2008526854 A5 JP2008526854 A5 JP 2008526854A5 JP 2007550431 A JP2007550431 A JP 2007550431A JP 2007550431 A JP2007550431 A JP 2007550431A JP 2008526854 A5 JP2008526854 A5 JP 2008526854A5
- Authority
- JP
- Japan
- Prior art keywords
- kit
- group
- prostaglandin
- dose kit
- sealed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000013543 active substance Substances 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 6
- 230000000699 topical effect Effects 0.000 claims description 6
- 125000003259 prostaglandin group Chemical group 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- HSMMSDWNEJLVRY-INIZCTEOSA-N dodecyl (2s)-2-(dimethylamino)propanoate Chemical group CCCCCCCCCCCCOC(=O)[C@H](C)N(C)C HSMMSDWNEJLVRY-INIZCTEOSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 239000000945 filler Substances 0.000 claims 4
- 150000001733 carboxylic acid esters Chemical class 0.000 claims 3
- 239000007788 liquid Substances 0.000 claims 3
- 239000003961 penetration enhancing agent Substances 0.000 claims 3
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical group CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- -1 prostaglandin E group compound Chemical class 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000002562 thickening agent Substances 0.000 claims 2
- 150000001298 alcohols Chemical group 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 239000002518 antifoaming agent Substances 0.000 claims 1
- 239000003125 aqueous solvent Substances 0.000 claims 1
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 238000010422 painting Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 claims 1
- CBOMORHDRONZRN-QLOYDKTKSA-N prostaglandin E3 Chemical compound CC\C=C/C[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O CBOMORHDRONZRN-QLOYDKTKSA-N 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 150000003505 terpenes Chemical class 0.000 claims 1
- 235000007586 terpenes Nutrition 0.000 claims 1
- 239000000463 material Substances 0.000 description 2
- GJGOEPNSCVWOLP-UHFFFAOYSA-N C(CC)(=O)OCC(CCCCCCCCCC)N(C)C Chemical compound C(CC)(=O)OCC(CCCCCCCCCC)N(C)C GJGOEPNSCVWOLP-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/030,506 US20050181030A1 (en) | 2003-01-03 | 2005-01-06 | Topical stabilized prostaglandin E compound dosage forms |
| PCT/US2006/000147 WO2006074204A2 (en) | 2005-01-06 | 2006-01-06 | Topical stabilized prostaglandin e compound dosage forms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013216316A Division JP2014055144A (ja) | 2005-01-06 | 2013-10-17 | 局所安定化プロスタグランジンｅ化合物剤形 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526854A JP2008526854A (ja) | 2008-07-24 |
| JP2008526854A5 true JP2008526854A5 (enExample) | 2013-01-17 |
Family
ID=36648128
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007550431A Withdrawn JP2008526854A (ja) | 2005-01-06 | 2006-01-06 | 局所安定化プロスタグランジンｅ化合物剤形 |
| JP2013216316A Withdrawn JP2014055144A (ja) | 2005-01-06 | 2013-10-17 | 局所安定化プロスタグランジンｅ化合物剤形 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013216316A Withdrawn JP2014055144A (ja) | 2005-01-06 | 2013-10-17 | 局所安定化プロスタグランジンｅ化合物剤形 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050181030A1 (enExample) |
| EP (1) | EP1855648A4 (enExample) |
| JP (2) | JP2008526854A (enExample) |
| KR (2) | KR20140006083A (enExample) |
| CN (1) | CN101132763A (enExample) |
| AU (1) | AU2006204069A1 (enExample) |
| CA (1) | CA2592978C (enExample) |
| IL (1) | IL184322A0 (enExample) |
| MX (1) | MX2007008325A (enExample) |
| WO (1) | WO2006074204A2 (enExample) |
| ZA (1) | ZA200705516B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
| CN1777429A (zh) | 2003-04-02 | 2006-05-24 | 尼克美制药控股有限公司 | 前列腺素组合物和其治疗血管痉挛的应用 |
| GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
| GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
| GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
| US7560489B2 (en) * | 2006-10-11 | 2009-07-14 | Nexmed Holdings, Inc. | Stabilized prostaglandin E composition |
| GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
| US20090054497A1 (en) * | 2007-08-21 | 2009-02-26 | Nawaz Ahmad | Methods for attaining enhanced sexual wellness using anhydrous compositions |
| US20090054498A1 (en) * | 2007-08-21 | 2009-02-26 | Nawaz Ahmad | Anhydrous Compositions Useful for Attaining Enhanced Sexual Wellness |
| US20130211353A1 (en) * | 2010-10-28 | 2013-08-15 | Hisamitsu Pharmaceutical Co., Inc. | Percutaneous absorption type formulation |
| EP2646015B1 (en) * | 2010-12-02 | 2020-04-22 | Ferring International Center S.A. | Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate |
| MX342511B (es) | 2011-04-07 | 2016-10-03 | Nexmed Holdings Inc | Metodos y composiciones para tratar la enfermedad de raynaud. |
| ITMI20121462A1 (it) * | 2012-08-31 | 2014-03-01 | Francesco Maria Bulletti | Preparato a rilascio vaginale per la diagnosi della pervietà e della funzione utero tubarica femminile umana finalizzata alla fecondazione dei gameti |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US623241A (en) * | 1899-04-18 | Machine for trimming oil-cakes | ||
| US4136162A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| SE431821B (sv) * | 1979-01-29 | 1984-03-05 | Perstorp Ab | Lagringsstabilt, prostaglandininnehallande medicinskt preparat |
| IE59361B1 (en) * | 1986-01-24 | 1994-02-09 | Akzo Nv | Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension |
| US5166174A (en) * | 1987-01-28 | 1992-11-24 | K.K. Ueno Seiyaku Oyo Kenkyujo | Prostaglandins E and anti-ulcers containing same |
| US20020004529A1 (en) * | 1997-10-20 | 2002-01-10 | Gary W. Neal | Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| US6593369B2 (en) * | 1997-10-20 | 2003-07-15 | Vivus, Inc. | Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| US5877216A (en) * | 1997-10-28 | 1999-03-02 | Vivus, Incorporated | Treatment of female sexual dysfunction |
| US6414028B1 (en) * | 1997-11-05 | 2002-07-02 | Nexmed Holdings, Inc. | Topical compositions containing prostaglandin E1 |
| US6046244A (en) * | 1997-11-05 | 2000-04-04 | Nexmed Holdings, Inc. | Topical compositions for prostaglandin E1 delivery |
| US5942545A (en) * | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
| DE69927154T2 (de) * | 1998-06-25 | 2006-06-29 | Lavipharm Laboratories, Inc. | Vorrichtung und verfahren zur behandlung von erektionsstörungen |
| US20040110843A1 (en) * | 2000-01-10 | 2004-06-10 | Nexmed (Holdings), Inc. | Methods of treatment of male erectile dysfunction |
| US20020107230A1 (en) * | 2000-12-22 | 2002-08-08 | Waldon R. Forrest | Methods and formulations for the treatment of female sexual dysfunction |
| WO2004022064A1 (en) * | 2002-09-06 | 2004-03-18 | Nexmed (Holdings), Inc. | Methods of treatment of male erectile dysfunction |
| US6841574B2 (en) * | 2003-01-03 | 2005-01-11 | Nexmed Holdings, Inc. | Topical stabilized prostaglandin E compound dosage forms |
-
2005
- 2005-01-06 US US11/030,506 patent/US20050181030A1/en not_active Abandoned
-
2006
- 2006-01-06 WO PCT/US2006/000147 patent/WO2006074204A2/en not_active Ceased
- 2006-01-06 JP JP2007550431A patent/JP2008526854A/ja not_active Withdrawn
- 2006-01-06 AU AU2006204069A patent/AU2006204069A1/en not_active Abandoned
- 2006-01-06 EP EP06717366A patent/EP1855648A4/en not_active Withdrawn
- 2006-01-06 MX MX2007008325A patent/MX2007008325A/es active IP Right Grant
- 2006-01-06 KR KR1020137031609A patent/KR20140006083A/ko not_active Ceased
- 2006-01-06 CA CA2592978A patent/CA2592978C/en active Active
- 2006-01-06 KR KR1020077018083A patent/KR20070094836A/ko not_active Ceased
- 2006-01-06 CN CNA2006800068328A patent/CN101132763A/zh active Pending
-
2007
- 2007-07-01 IL IL184322A patent/IL184322A0/en unknown
- 2007-07-05 ZA ZA200705516A patent/ZA200705516B/xx unknown
-
2013
- 2013-10-17 JP JP2013216316A patent/JP2014055144A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008526854A5 (enExample) | ||
| US10238612B2 (en) | Transdermal administration of tamsulosin | |
| US20170112780A1 (en) | Pharmaceutical composition for application to nail | |
| FR2613233A1 (fr) | Systeme therapeutique transdermique pour combinaisons de substances actives, procedes pour sa preparation et utilisation d'oestrogenes dans la preparation d'un tel systeme | |
| JP2012526140A5 (enExample) | ||
| JP4874486B2 (ja) | 気管支拡張剤ツロブテロールを皮膚から投与するための塩酸ツロブテロールを含む経皮治療システム | |
| EP2491924B1 (en) | Water-based paste containing diclofenac sodium | |
| JP2006514068A5 (enExample) | ||
| SK51595A3 (en) | Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline active ingredients, and processs for producing the same | |
| CA2512015A1 (en) | Topical stabilized prostaglandin e compound dosage forms | |
| TW201628604A (zh) | 膏劑 | |
| US6592891B1 (en) | Plaster for topical use containing heparin and diclofenac | |
| CA2845165C (en) | Composition for enhancing transdermal absorption of drug and patch preparation | |
| JP6104222B2 (ja) | 非ステロイド系消炎鎮痛貼付剤 | |
| TW201628605A (zh) | 膏劑 | |
| JP5723823B2 (ja) | 非ステロイド系消炎鎮痛貼付剤 | |
| US9861598B2 (en) | Ketoprofen lysine salt-containing aqueous patch | |
| JP2003530354A (ja) | 経皮製剤において高親油性有効成分の透過促進剤として利用するための組成物 | |
| TWI451884B (zh) | 含有鹽酸布特那芬之水性貼附劑 | |
| KR20090132173A (ko) | 록소프로펜 또는 그의 염을 포함하는 경피 흡수용 조성물및 이를 포함하는 경피 투여 첩부제 | |
| BR112014013566B1 (pt) | Emplastro contendo fármaco anti-inflamatório não-esteroidal | |
| WO2019059376A1 (ja) | ６－デオキシ－７，８－ジヒドロ－６－オキソモルヒネ骨格を有する化合物を薬効成分とする外用剤組成物 | |
| HK1038502A (en) | Composition for the transdermal administration of non-steroidal anti-inflammatory drugs | |
| JP2019043853A (ja) | 経皮吸収促進剤、経皮吸収促進助剤、及び経皮製剤 | |
| JPS63152316A (ja) | 経皮吸収製剤 |